Impact of obesity in patients with congestive heart failure

Reviews in Cardiovascular Medicine

Volumn 10, Issue 3, 2009, Pages 142-151

  Kunju, Shebna Unes ^a   Badarudeen, Sameer ^a   Schwarz, Ernst R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Heart failure; Obesity; Reverse epidemiology; Weight reduction

Indexed keywords

DIGOXIN; PLACEBO; SIBUTRAMINE;

BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CACHEXIA; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DIET RESTRICTION; EXERCISE; GASTRIC BANDING; GASTROPLASTY; HUMAN; MORBID OBESITY; OBESITY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; STOMACH BYPASS; SURVIVAL RATE; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; COMBINED MODALITY THERAPY; DIET; DISEASE PROGRESSION; EXERCISE; HEART FAILURE; HUMANS; OBESITY; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 77952135934     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0480     Document Type: Review

References (80)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
2. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529.
3. Evangelista LS, Miller PS. Overweight and obesity in the context of heart failure: implications for practice and future research. J Cardiovasc Nurs. 2006;21:27-33.
4. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-el71.
5. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol. 1993;22:3A-5A.
6. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
7. Chen YT, Vaccarino V, WUliams CS, et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106:605-612.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
9. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996-1002.
10. Metropolitan Life Insurance Company. New weight standards for men and women. Stat Bull Metropol Life Insur Co; 1959:40.
11. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G. Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med. 2001;249:253-261.
12. Stamler J. Epidemiologic findings on body mass and blood pressure in adults. Ann Epidemiol. 1991;1:347-362.
13. Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978;240:1607-1610.
14. Kenchaiah S, Gaziano JM, Vasan RS. Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am. 2004;88:1273-1294.
15. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-969.
16. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.
17. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003;32:855-867.
18. Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993;153:1093-1103.
19. Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401-410.
20. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321:225-236.
21. Wildman RP, Mackey RH, Bostom A, et al. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003;42:468-473.
22. Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429-433.
23. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006,113:898-918.
24. Kasper EK, Hruban RH, Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol. 1992;70:921-924.
25. Vasan RS. Cardiac function and obesity. Heart. 2003;89:1127-1129.
26. Jubber AS. Respiratory complications of obesity. Int J Clin Pract. 2004;58:573-580.
27. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Prog Cardiovasc Dis. 1999;42:39-58.
28. Balkau B, Deanfield JE, Despres JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007;116:1942-1951.
29. Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29-35.
30. Curtis JP, Seller JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55-61.
31. Kalantar-Zadeh K, Anker SD, Coats AJ, et al. Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med. 2005;165:1797.
32. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional
33. cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43:1439-1444.
34. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793-808.
35. Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789-795.
36. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891-894.
37. Gustafsson F, Kragelund CB, Torp-Pedersen C, et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: Influence of left ventricular systolic function. Eur Heart J. 2005;26:58-64.
38. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with Captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992;19:842-850.
39. Vredevoe DL, Woo MA, Doering LV, et al. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82:323-328.
40. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993; 328:313-318.
41. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000;356:930-933.
42. Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971-E975.
43. Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537-544.
44. Weber MA, Neutel JM, Smith DH. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol. 2001;37:169-174.
45. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
46. Coats AJ, Adamopoulos S, Meyer TE, et al. Effects of physical training in chronic heart failure. Lancet. 1990;335:63-66.
47. Bayes-Genls A, DeFilippi C, Januzzi JL Jr. Understanding amlno-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol. 2008;101:89-94.
48. Lavie CJ, Milani R, Mehra MR, et al. Obesity, weight reduction and survival in heart failure. J Am Coll Cardiol. 2002;39:1563.
49. Alexander JK, Dennis EW, Smith WG, et al. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull. 1962;1:39-44.
50. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80:736-740.
51. Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am J Cardiol. 1995;76:1198-1201.
52. Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant. 1999;18:750-763.
53. Zuber M, Kaeslin T, Studer T, Erne P. Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient. Am J Cardiol. 1999;84:955-956.
54. Kanda T, Saegusa S, Takahashi T, et al. Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression. Int J Cardiol. 2007;119:310-318.
55. Mariotti R, Castrogiovanni F, Canale ML, et al. Weight loss and quality of life in chronic heart failure patients. J Cardiovasc Med (Hagerstown). 2008;9:576-580.
56. Kostis JB, Rosen RC, Cosgrove NM, et al. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure. Chest. 1994;106:996-1001.
57. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919-923.
58. Bittner V. Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J. 1999;138:593-596.
59. McMahon FG, Fujioka K, Singh BN, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2000;160:2185-2191.
60. Alden PB, Madoff RD, Stahl TJ, et al. Left ventricular function in malnutrition. Am J Physiol. 1987;253:H380-H387.
61. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335:609-616.
62. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-588.
63. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1997;96:3248-3250.
64. Beck-da-Silva L, Higginson L, Fraser M, et al. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail. 2005;11:118-123.
65. Ershow AG, Costello RB. Dietary guidance in heart failure: a perspective on needs for prevention and management. Heart Fail Rev. 2006;11:7-12.
66. Uren NG, Lipkin DP. Exercise training as therapy for chronic heart failure. Br Heart J. 1992;67:430-433.
67. Lee AP, Ice R, Blessey R, Sanmarco ME. Longterm effects of physical training on coronary patients with impaired ventricular function. Circulation. 1979;60:1519-1526.
68. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation. 1988;78:506-515.
69. Ehsani AA. Adaptations to training in patients with exercise-induced left ventricular dysfunction. Adv Cardiol. 1986;34:148-155.
70. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999;99:1173-1182.
71. McCloskey CA, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3:503-507.
72. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053.
73. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting In AIDS. Am J Clin Nutr. 1989;50:444-457.
74. Ohashi H, Oda H, Ohno M, Sakata S. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of left ventricular hypertrophy and diabetic nephropathy. Adv Perit Dial. 1999;15:87-90.
75. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc. 1999;58:321-328.
76. Boersma F, Van Den Brink W, Deeg DJ, et al. Survival in a population-based cohort of dementia patients: predictors and causes of mortality. Int J Geriatr Psychiatry. 1999;14:748-753.
77. Tisdale M. Cachexia in cancer patients. Nat Rev Cancer. 2002;2:862-871.
78. Abel RM, Fischer JE, Buckley MJ, et al. Malnutrition in cardiac surgical patients. Results of a prospective, randomized evaluation of early postoperative parenteral nutrition. Arch Surg. 1976;111:45-50.
79. Engelman DT, Adams DH, Byrne JG, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118:866-873.
80. Schwengel RH, Gottlieb SS, Fisher ML. Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure. Am J Cardiol. 1994;73:908-910.